LabCompass

Lei Chen

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Cancer, Lipids, and MetabolismProstate Cancer Treatment and ResearchUrinary Bladder and Prostate ResearchFerroptosis and cancer prognosisPI3K/AKT/mTOR signaling in cancer

Publications

77

Citations

945

Est. group size

—

Recurring co-author estimate

Active years

12

Publishing since 2015

Research summary
AI-generated

Lei Chen's research spans cancer biology and molecular medicine, with recurring work on how signaling pathways drive tumor growth, cell death (including ferroptosis, an iron-dependent form of programmed cell death), and disease progression. The publication record also covers prostate inflammation (prostatitis), immune cell responses, and a range of clinical topics such as pregnancy outcomes and respiratory disease. Studies frequently combine laboratory experiments with bioinformatics and clinical data analysis.

Cancer signaling and cell death (ferroptosis)Prostate disease and inflammationImmune cell responses and pathways (JAK/STAT)Bioinformatics and biomarker predictionClinical and translational medicine

Publication activity rose sharply around 2022-2023 after a steadier earlier period, then settled to a moderate pace in the most recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 10.6/year recently
2017: 2 publications172018: 3 publications182019: 4 publications192020: 6 publications202021: 3 publications212022: 17 publications222023: 18 publications18232024: 7 publications242025: 9 publications252026: 2 publications26
Recent publications
Publishes in
  • Figshare×6
  • SSRN Electronic Journal×3
  • Neurochemical Research×2
  • Journal of Cellular and Molecular Medicine×2
  • Disease Markers×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile